AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases

Keyphrases

• Clinical Practice Guidelines 100%
• Gastrointestinal Diseases 100%
• American Gastroenterological Association 100%
• Fecal Microbiota Transplantation 85%
• Standard of Care 42%
• Difficile 42%
• Antibiotics 42%
• C.difficile Infection 28%
• Inflammatory Bowel Disease 28%
• Irritable Bowel Syndrome 28%
• Fecal Microbiota 28%
• Recurrent C. Difficile Infection 28%
• Immunocompromised Adults 28%
• Guideline Panel 28%
• Clinical Trials 14%
• U.S. Food 14%
• Clostridium Difficile Infection 14%
• Effective Therapy 14%
• Adjuvant Therapy 14%
• Clinical Practice 14%
• Prevent Recurrence 14%
• Pouchitis 14%
• Patient-centered Outcomes 14%
• Assessment Development 14%
• Grading of Recommendations 14%
• Evaluation Assessment 14%
• Evaluation Framework 14%
• Assessment Framework 14%
• Immunocompetent Adult 14%
• Evidence to Decision Framework 14%
• Recommendation Framework 14%
• Development Framework 14%

Medicine and Dentistry

• Transplantation 100%
• Gastrointestinal Disease 100%
• Clostridium Difficile Infection 66%
• Fulminant 50%
• Antibiotics 50%
• Irritable Bowel Syndrome 33%
• Inflammatory Bowel Disease 33%
• Infection 16%
• Clinical Trial 16%
• Recurrent Disease 16%
• Adjuvant Therapy 16%
• Pouchitis 16%
• Spore 16%